Written by Swikriti
The Chicago Cubs closing in on a deal for Miami Marlins right-hander Edward Cabrera has created a familiar winter question: did the Cubs just win a real pitching upgrade, or did the New York Yankees dodge a risky bet at the right time? Based on what’s been reported so far, the honest answer is that both teams can claim a rational “win”—but the Cubs are the ones taking the swing that could change their 2026 ceiling.
Multiple reports have the Cubs nearing the finish line on Cabrera, a power arm coming off a breakout 2025 season. Reuters reported Chicago is close to acquiring Cabrera, with trade details still developing at the time of publication, including the possibility of a top prospect headlining the return package. Here’s the Reuters report.
Meanwhile, the Yankees were connected to Cabrera in talks with Miami, but reporting in New York suggested they were “never close” to a deal. The key context: New York’s rotation health picture is already fragile, and taking on another pitcher with durability questions would have compounded that risk. The New York Post framed it that way.
The case that the Cubs “won” the moment
If you’re Chicago, Cabrera is exactly the kind of target that makes sense: high-upside, controllable, and capable of pitching like a No. 2 starter when right. The Cubs’ recent rotations have often relied on stability over volatility; Cabrera introduces the kind of electric, swing-and-miss profile that can tilt a playoff series—if he’s healthy and repeating his 2025 improvements.
On paper, he’s an upgrade type the Cubs can justify paying for because the roster fit is clear: he slides into a group that already includes established starters, allowing Chicago to chase more impact without forcing Cabrera to be “the guy” every fifth day. That matters for both performance and workload management. In other words, the Cubs don’t need perfection from Cabrera—just enough healthy months to convert upside into wins.
Why this is a bold (and potentially brilliant) Cubs move:
- Ceiling play: Cabrera’s best stretches look like frontline stuff, not back-end innings.
- Control window: Cost-controlled seasons create roster flexibility to add bats or bullpen help later.
- Rotation depth strategy: With other starters in place, Cabrera can be supported, not overused.
The case that the Yankees didn’t “miss out” at all
For the Yankees, the Cabrera idea is exciting in theory and terrifying in practice. The upside is real: a hard thrower with strikeout ability and years of control is exactly what a contender wants. The problem is timing. If your early-season rotation plan is already built around patchwork—because multiple starters are expected to miss time—then the last thing you can do is add another pitcher with a meaningful injury track record and hope the baseball gods cooperate.
In a vacuum, Cabrera’s risk might be manageable. But roster construction is not a vacuum. New York’s situation makes this a “risk stacking” problem: if two things go wrong at once, you’re scrambling for innings and burning your bullpen in April. That’s how good seasons become exhausting seasons.
Why passing can be the “smart loss” for the Yankees:
- Injury math: If your rotation already has red flags, adding another can be a self-inflicted crisis.
- Trade cost: Miami would likely demand premium talent; the Yankees can redirect that capital.
- Better-fit targets: New York can prioritize durability or established volume over pure upside.
So… who actually missed out?
If Cabrera stays healthy and even approaches his 2025 level again, the Yankees will look like the team that let a difference-maker get away, while the Cubs will look proactive and opportunistic. That’s the outcome Cubs fans are buying with this move.
But if Cabrera’s durability issues resurface—short starts, IL stints, inconsistent availability—then the Yankees didn’t miss out. They avoided paying a premium for a player who can’t reliably solve the exact problem they’re trying to fix: dependable innings early in the year.
The fairest takeaway: the Cubs are making the higher-upside bet; the Yankees are choosing the lower-risk path. The “winner” won’t be decided on trade day—it’ll be decided by how many healthy, effective starts Cabrera gives Chicago from April through September.
